Stay updated with breaking news from Nasdaq ikna. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ikena Oncology, Inc. (NASDAQ:IKNA – Get Rating) – Stock analysts at Jefferies Financial Group issued their Q3 2023 earnings per share (EPS) estimates for Ikena Oncology in a research report issued on Sunday, March 19th. Jefferies Financial Group analyst K. Shi anticipates that the company will post earnings per share of ($0.48) for the quarter. […] ....
Ikena Oncology (NASDAQ:IKNA – Get Rating) and Adaptimmune Therapeutics (NASDAQ:ADAP – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, risk, profitability, valuation, dividends, institutional ownership and earnings. Risk and Volatility Ikena Oncology has a beta of […] ....
Ikena Oncology (NASDAQ:IKNA – Get Rating) is one of 254 public companies in the “Biological products, except diagnostic” industry, but how does it weigh in compared to its peers? We will compare Ikena Oncology to similar companies based on the strength of its dividends, earnings, analyst recommendations, risk, profitability, institutional ownership and valuation. Earnings & […] ....
Ikena Oncology (NASDAQ:IKNA – Get Rating) is one of 254 public companies in the “Biological products, except diagnostic” industry, but how does it contrast to its peers? We will compare Ikena Oncology to related businesses based on the strength of its profitability, analyst recommendations, risk, earnings, institutional ownership, dividends and valuation. Valuation & Earnings This […] ....
Ikena Oncology (NASDAQ:IKNA – Get Rating) is one of 254 publicly-traded companies in the “Biological products, except diagnostic” industry, but how does it contrast to its competitors? We will compare Ikena Oncology to related companies based on the strength of its risk, institutional ownership, valuation, dividends, analyst recommendations, earnings and profitability. Earnings & Valuation This […] ....